Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Analyst Color
  • Earnings
  • Earnings Misses
  • Equities
  • News
  • Price Target
  • Tech
  • Top Stories
  • Trading Ideas

Tesla’s Rare Double Miss: Analyst Expects Wall Street To Revise Estimates After Q3 Earnings Call Earns ‘Not Good’ To ‘Terrible’ Reviews

By Shanthi Rexaline
October 19, 4:16 AM
Tesla's revenue fell short of expectations, marking the first time both headline numbers missed estimates since the second quarter of 2019.

FFND

Read More
2 minute read
  • Analyst Color
  • Biotech
  • Equities
  • Health Care
  • Long Ideas
  • News
  • Specialty ETFs
  • Top Stories
  • Trading Ideas

Eli Lilly To Fly Higher? Fund Manager Gary Black Envisions Blockbuster Potential For Diabetes Drug Mounjaro

By Shanthi Rexaline
October 12, 4:40 AM
Lilly stock has been on a tear this year, thanks to the huge potential its GLP-1 agonist Mounjaro promises.

FFND

Read More
2 minute read
  • Analyst Color
  • Equities
  • News
  • Top Stories

Tesla Investor Says ‘Short-Term Narcotic’ Price Cuts Won’t Work: ‘Sad That..Mgmt Doesn’t Get This’

By Shanthi Rexaline
September 2, 4:52 AM
Tesla Inc.‘s (NASDAQ:TSLA) sharp Model S, X price cuts in the U.S. this week triggered a backlash from…

FFND

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Long Ideas
  • News
  • Price Target
  • Top Stories
  • Trading Ideas

Tesla Analyst Explains Stock’s 12% Post-Earnings Pullback: 9 Catalysts That Can Stall The Sell-Off

By Shanthi Rexaline
July 28, 5:00 AM
Tesla stock began declining in the session ahead of its earnings release and it has been broadly lower since then.

FFND

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • ETFs
  • Long Ideas
  • Markets
  • News
  • Top Stories
  • Trading Ideas

Tesla’s Price Cuts Produce ‘Sugar High’ But Lack Long-Term Benefit, Says Analyst: Ad Campaign ‘Would Surely Help’

By Shanthi Rexaline
April 24, 3:11 AM
Wall Street analysts have not been big fans of Tesla, Inc.

FFND

Read More
2 minute read
  • Media
  • News
  • Small Cap

WeightWatchers Latest Strategic Acquisition: Simplify Insurance Reimbursement For Costly Weight-Loss Drugs

By Anusuya Lahiri
April 14, 9:28 AM
WW International, Inc (NASDAQ:WW) or WeightWatchers snapped telemedicine company Sequence in March after scanning through 30 different startups that prescribe obesity medications,…

FFND

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Markets
  • News
  • Price Target
  • Short Sellers
  • Trading Ideas

Goldman Sachs Thesis On Weight Watchers Is ‘Absurd,’ Fund Manager Says Why He’d Short The Stock

By Natan Ponieman
April 12, 12:56 PM
Shares of WW International Inc (NASDAQ:WW), the parent company of diet and fitness platform Weight Watchers, jumped almost…

FFND

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Long Ideas
  • News
  • Trading Ideas

What’s Next After Tesla’s 58% YTD Rally? Analyst Expects This Key Event To Bring More Upside

By Shanthi Rexaline
February 7, 2:20 AM
The Tesla Inc.

FFND

Read More
4 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Federal Reserve
  • News
  • Previews
  • Tech
  • Top Stories
  • Trading Ideas

Tesla’s Q4 Report To Drop On Wednesday: What Investors Should Expect From Challenging Quarter

By Shanthi Rexaline
January 24, 9:43 AM
As Tesla Inc.

BYDDF

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Tech
  • Trading Ideas

Who Is Tesla’s ‘Real CEO?’ Elon Musk’s Preoccupation With Twitter Worries One Of EV Maker’s Most-Vocal Backers

By Shanthi Rexaline
December 13, 7:25 AM
Tesla Inc. (NASDAQ: TSLA) shares fell 6.27% on Monday, defying the broader market rally. The pullback steepened the stock’s year-to-date loss to 52.4%.

FFND

Posts pagination

Previous 1 2
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service